PubMed HealthSearch

Biomedical subjects

R Othman

Publications and source records attributed to R Othman.

5 recordsLinked to original sources

Mapping the interfacial binding surface of human secretory group IIa phospholipase A2.

Human secretory group IIa phospholipase A2 (hIIa-PLA2) contains a large number of prominent cationic patches on its molecular surface and has exceptionally high affinity for anionic surfaces, including anionic membranes. To identify the cationic amino acid residues that support binding of hIIa-PLA2 to anionic membranes, we have performed extensive site-directed mutagenesis of this protein and measured vesicle binding and interfacial kinetic properties of the mutants using polymerized liposomes and nonpolymerized anionic vesicles. Unlike other secretory PLA2s, which have a few cationic residues that support binding of enzyme to anionic membranes, interfacial binding of hIIa-PLA2 is driven in part by electrostatic interactions involving a number of cationic residues forming patches on the putative interfacial binding surface. Among these residues, the amino-terminal patch composed of Arg-7, Lys-10, and Lys-16 makes the most significant contribution to interfacial adsorption, and this is supplemented by contributions from other patches, most notably Lys-74/Lys-87/Arg-92 and Lys-124/Arg-127. For these mutants, complete vesicle binding occurs in the presence of high vesicle concentrations, and under these conditions the mutants display specific activities comparable to that of wild-type enzyme. These studies indicate that electrostatic interactions between surface lysine and arginine residues and the interface contribute to interfacial binding of hIIa-PLA2 to anionic vesicles and that cationic residues closest to the opening of the active-site slot make the most important interactions with the membrane. However, because the wild type binds extremely tightly to anionic vesicles, it was not possible to exactly determine what fraction of the total interfacial binding energy is due to electrostatics.

Arginine

Human non-pancreatic (group II) secreted phospholipase A2 expressed from a synthetic gene in Escherichia coli: characterisation of N-terminal mutants.

A gene coding for human non-pancreatic (group II) secreted phospholipase A2 (hnpsPLA2) has been constructed by the single-step ligation of twelve synthetic oligonucleotides. The gene has been cloned into a modification of the bacterial expression vector pET 11 which allows protein over-expression as inclusion bodies and enables about 3 mg/litre of pure refolded fully active enzyme to be obtained. The protein was expressed as a 1-Ala mutant (N1A) to allow removal of the initiator methionine by the Escherichia coli amino-peptidase. This mutant had very similar properties to the wild-type enzyme. A double mutant, N1A, V3W was also constructed and expressed in high yield. This tryptophan-containing mutant showed similar properties to the wild-type and N1A mutant but had about 40% of the activity under the assay conditions used. This tryptophan was used as a reporter group for interfacial binding and its properties were compared to those of the corresponding tryptophan in PLA2 from procine pancreas. Expression of the wild-type gene sequence for hnpsPLA2 in E. coli gave the expected mutant protein still with the initiator methionine and with much reduced activity. Interfacial binding of all hnpsPLA2 mutants to anionic phospholipids was very similar when assessed by fluorescence methods. Comparisons of these mutants with the pancreatic enzyme revealed significant differences in terms of the effect of calcium on interfacial binding. The ability to express reasonably large amounts of the N1A mutant in E. coli will provide a basis for future site directed mutagenesis studies of this important human enzyme.

Amino Acid Sequence

Interactive database management (IDM).

Interactive database management (IDM) is a data editing software that provides complete data editing at the time of initial data entry when information is 'fresh at hand'. Under the new interactive system, initial data recording is subjected to instant data editing by the interactive computer software logic. Data are immediately entered in final form to the database and are available for analysis. IDM continuously checks all variables for acceptability, completeness, and consistency. IDM does not allow form duplication. Many functions including backups have been automated. The interactive system can export the database to other systems. The software has been implemented for two Department of Veterans Affairs Cooperative Studies (CCSHS #5 and CSP #385) which collect data for 1400 and 1000 variables, respectively at 28 VA medical centers. IDM is extremely user friendly and simple to operate. Researchers with no computer background can be trained quickly and easily to use the system. IDM is deployed on notebook microcomputers making it portable for use anywhere in the hospital setting.

Clinical Trials as Topic

Traditional psychotherapeutic healing and healers in the Palestinian community.

The aim of this paper is to offer some general observations about traditional psychotherapeutic healing and healers in the Palestinian community. Ten healers, known as sheikhs or sheikhas, were interviewed, and their statements comprise the principal data on which this study is based. Observations are offered regarding (1) the background, training and some characteristics of the healers; (2) characteristics of the patients and illnesses treated; (3) therapeutic techniques and treatment rationale.

Adult